Spikevax 2025-26 (12Y up) syrg 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1QAK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,053
Award facts
- Contract value 100% obligated
- $1,052.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for $1,052.80 to supply SPIKEVAX 2025-26 vaccine for ages 12 and up in 0.5ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of February 4, 2026, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. All of the company's contract awards are competitively awarded on a full and open basis, demonstrating its capability to meet rigorous federal procurement requirements. Through its parent company Cencora, Inc., the organization also maintains a significant IDC with DLA valued at up to $999,999,999.00 through December 2031, underscoring its strategic importance to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1QAK?
SPE2DR26F1QAK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1QAK worth?
The government has obligated $1,053 on SPE2DR26F1QAK.
Is contract SPE2DR26F1QAK an order under another contract?
Yes. SPE2DR26F1QAK is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QAK competed?
The extent of competition for SPE2DR26F1QAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award